<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate whether epigenotyping of patients with isolated hemihyperplasia (IH) can, analogous to genetic screening of patients with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, be used for the prediction of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> risk and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type of individual patients </plain></SENT>
<SENT sid="1" pm="."><plain>STUDY DESIGN: Methylation analysis of H19 and KCNQ1OT1 of 73 patients </plain></SENT>
<SENT sid="2" pm="."><plain>Questionnaires were sent to referring clinicians </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In 75% of the clinically confirmed patients with IH no epigenetic defect was detected </plain></SENT>
<SENT sid="4" pm="."><plain>Paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> was found in 15%, demethylation of KCNQ1OT1 in only 6%, and hypermethylation of H19 in 3% of isolated hemihyperplasia cases </plain></SENT>
<SENT sid="5" pm="."><plain>Ten percent of the patients with IH had development of a <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">childhood tumor</z:e> associated with paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> (2/8) or no methylation defect (2/30) </plain></SENT>
<SENT sid="6" pm="."><plain>No genetic defect was detected in 10 of 14 additional patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> with IH </plain></SENT>
<SENT sid="7" pm="."><plain>In these latter patients, a methylation defect of H19 was seen 3 times and a paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> once </plain></SENT>
<SENT sid="8" pm="."><plain>The female-to-male ratio was 6:1 </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Aberrant methylation of the 11p15 region is not common in patients with IH and can at present not be used for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> risk determination </plain></SENT>
</text></document>